Leaflet CO-DOLNIX 16mg / 12.5mg tablets


Indicated for: hypertension

Route of administration: oral

Substance: desartan cilexetil + hydrochlorothiazide (antihypertensive + diuretic)

ATC: C09CA06 (Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain)

The combination of Desartanum cilexetil + Hydrochlorothiazidum is used for the treatment of essential hypertension in patients who do not respond adequately to monotherapy. It combines an angiotensin II receptor antagonist (desartanum cilexetil) with a thiazide diuretic (hydrochlorothiazidum) to lower blood pressure.

The medication is taken orally, usually once daily, and is effective in reducing the risk of cardiovascular complications such as stroke or myocardial infarction.

Side effects may include dizziness, headache, nausea, hypokalemia, or increased uric acid levels. It is important to monitor blood pressure and kidney function during treatment.

Consult your doctor to discuss the benefits and risks of treatment with Desartanum cilexetil + Hydrochlorothiazidum. Follow the prescribed dosage and adhere to all medical recommendations.

General data about CO-DOLNIX 16mg / 12.5mg

  • Substance: desartan cilexetil + hydrochlorothiazide
  • Date of last drug list: 01-07-2013
  • Commercial code: W56327001
  • Concentration: 16mg / 12.5mg
  • Pharmaceutical form: tablets
  • Quantity: 28
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.